Form 4: BeiGene CEO Sells Shares
Insider Transaction (Form 4)
John Oyler, Chief Executive Officer and a Director of BeiGene, Ltd., sold 145,861 shares of common stock on July 14, 2026.
Summary
- Open-market sale: disposed of 4,139 American Depositary Shares at $303.07 ($1,254,401) on July 14, 2026; holds 8,122 after (Direct).
- Open-market sale: disposed of 8,122 American Depositary Shares at $303.93 ($2,468,490) on July 14, 2026 (Direct).
- Option exercise/conversion: acquired 97,282 American Depositary Shares at $36.90 ($3,589,706) on July 14, 2026; holds 97,282 after (Direct).
- Option exercise/conversion: acquired 36,318 American Depositary Shares at $100.04 ($3,633,253) on July 14, 2026; holds 133,600 after (Direct).
- Open-market sale: disposed of 39,090 American Depositary Shares at $305.02 ($11,923,259) on July 14, 2026; holds 94,510 after (Direct).
- Open-market sale: disposed of 45,895 American Depositary Shares at $306.21 ($14,053,627) on July 14, 2026; holds 48,615 after (Direct).
- Open-market sale: disposed of 40,781 American Depositary Shares at $306.93 ($12,517,112) on July 14, 2026; holds 7,834 after (Direct).
- Open-market sale: disposed of 7,834 American Depositary Shares at $307.57 ($2,409,534) on July 14, 2026 (Direct).
- Option exercise/conversion: disposed of 1,264,666 Share Option (Right to Buy) on July 14, 2026 (Direct).
- Option exercise/conversion: disposed of 472,134 Share Option (Right to Buy) on July 14, 2026; holds 462,866 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $44,626,424 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
John Oyler — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-14 | Open-market sale | American Depositary Shares | 4,139 | $303 | $1.3M | 8,122 |
| 2026-07-14 | Open-market sale | American Depositary Shares | 8,122 | $304 | $2.5M | 0 |
| 2026-07-14 | Option exercise/conversion | American Depositary Shares | 97,282 | $37 | $3.6M | 97,282 |
| 2026-07-14 | Option exercise/conversion | American Depositary Shares | 36,318 | $100 | $3.6M | 133,600 |
| 2026-07-14 | Open-market sale | American Depositary Shares | 39,090 | $305 | $11.9M | 94,510 |
| 2026-07-14 | Open-market sale | American Depositary Shares | 45,895 | $306 | $14.1M | 48,615 |
| 2026-07-14 | Open-market sale | American Depositary Shares | 40,781 | $307 | $12.5M | 7,834 |
| 2026-07-14 | Open-market sale | American Depositary Shares | 7,834 | $308 | $2.4M | 0 |
| 2026-07-14 | Option exercise/conversion | Share Option (Right to Buy) | 1,264,666 | — | — | 0 |
| 2026-07-14 | Option exercise/conversion | Share Option (Right to Buy) | 472,134 | — | — | 462,866 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-14 | Open-market sale (4,139 shares) |
| 2026-07-14 | Open-market sale (8,122 shares) |
| 2026-07-14 | Option exercise/conversion (97,282 shares) |
| 2026-07-14 | Option exercise/conversion (36,318 shares) |
| 2026-07-14 | Open-market sale (39,090 shares) |
| 2026-07-14 | Open-market sale (45,895 shares) |
| 2026-07-14 | Open-market sale (40,781 shares) |
| 2026-07-14 | Open-market sale (7,834 shares) |
| 2026-07-14 | Option exercise/conversion (1,264,666 shares) |
| 2026-07-14 | Option exercise/conversion (472,134 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, John Oyler
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.